abemaciclib and fulvestrant show improved efficacy in hr , her2- advanced breast cancer compared...
Published 1 month ago • 96 plays • Length 3:57Download video MP4
Download video MP3
Similar videos
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
5:44
falcon trial: fulvestrant vs. anastrozole for hr advanced breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
1:56
palmares-2: comparing first-line palbociclib, ribociclib, or abemaciclib in hr /her2- abc
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
5:34
monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer